• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Bionomics Ltd

+ Add to Watchlist


0.347 EUR 0.003 0.86%

As of 02:20:00 ET on 07/11/2014.

Snapshot for Bionomics Ltd (B1N)

Open: 0.348 Day's Range: 0.347 - 0.351 Volume: 0
Previous Close: 0.350 52wk Range: 0.222 - 0.581 1-Yr Rtn: +38.80%

Stock Chart for B1N

No chart data available.
  • B1N:GR 0.347
  • 1D
  • 1M
  • 1Y
Interactive B1N Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B1N

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 167.7235
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) 0.0030
Est. PEG Ratio -
Market Cap (M EUR) 144.82
Shares Outstanding (M) 417.36
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B1N

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for B1N

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field. The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Deborah RathjenManaging Director/CEOMelanie YoungCFO/Secretary
Jose IglesiasChief Medical Officer
More Company Profile & Key Executives for B1N

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil